Seeking Alpha·Aug 7, 2026
SIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call TranscriptSIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call Transcript
SIGA Technologies remains fundamentally tethered to the unpredictable timing of government biodefense procurement, creating a boom-bust cycle that obscures long-term value. While the company maintains a fortress balance sheet with zero long-term debt, the lack...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $0.17 vs — | $41M vs — |
Q2 2026 May 7, 2026 | -$0.05 vs — | $6M vs — |
Q2 2026 Mar 10, 2026 | -$0.08 vs — | $4M vs — |
Q4 2025 Nov 6, 2025 | -$0.09 vs — | $3M vs — |
SIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call Transcript
Siga Technologies NASDAQ: SIGA reported second-quarter product-related revenue of $38 million, driven primarily by deliveries of intravenous TPOXX to the U.S. Strategic National Stockpile and oral TPOXX sales to international customers. The company said the quarter reflected the variable timing of its government-focused procurement business after minimal product revenue in the first quarter.
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 6, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
Siga Technologies, Inc. remains a Hold, as revenue visibility hinges on BARDA contract renewal, with shares down ~40% since April. SIGA's sole commercial product, TPOXX, faces shrinking opportunities after losing EU approval for MPOX although mgmt is developing pediatric and PEP versions. Q1 2026 results showed stagnant revenues, widening losses, and reliance on a $26m BARDA delivery and $13m Asia Pacific contract.
Benchmark SIGA against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for SIGA Technologies, Inc. (SIGA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.17 | $227.37M | 9.61 | -31.8% | 24.63% | 11.24% | 19% | |
| $151.37 | $187.94B | 22.33 | 2.39% | -10.64% | -16.35% | — | |
| $15.30 | $667.11M | -2.62 | -86.62% | -170055.93% | -58.03% | — | |
| $8.40 | $349.8M | -2470.59 | 10.37% | 69.76% | — | — | |
| $516.34 | $131.05B | 33.70 | 9.57% | 34.89% | 23.31% | — | |
| $801.82 | $82.61B | 19.33 | 0.99% | 27.86% | 18.49% | — |
SIGA Technologies, Inc. (SIGA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
SIGA Technologies, Inc. (SIGA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jun 10, 2026·SEC
May 7, 2026·SEC
Get notified when SIGA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SIGA Technologies, Inc. (SIGA) stock FAQ — growth, dividends, profitability & financials explained
SIGA Technologies, Inc. (SIGA) reported $53.7M in revenue for fiscal year 2025. This represents a 53565% increase from $0.1M in 1996.
SIGA Technologies, Inc. (SIGA) saw revenue decline by 31.8% over the past year.
SIGA Technologies, Inc. (SIGA) reported a net loss of $2.8M for fiscal year 2025.
Yes, SIGA Technologies, Inc. (SIGA) pays a dividend with a yield of 19.00%. This makes it attractive for income-focused investors.
SIGA Technologies, Inc. (SIGA) has a return on equity (ROE) of 11.2%. This is reasonable for most industries.
SIGA Technologies, Inc. (SIGA) had negative free cash flow of $29.2M in fiscal year 2025, likely due to heavy capital investments.
